A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease
Clinical trial NCT04536792 · COMPLETED
Trial details
- NCT number
- NCT04536792
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2023-12-19
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.